Strides Pharma Science Limited (NSE:STAR)
608.40
-18.40 (-2.94%)
Mar 12, 2025, 3:30 PM IST
Strides Pharma Science Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 12, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 56,072 | 72,114 | 25,858 | 31,121 | 75,754 | 28,854 | Upgrade
|
Market Cap Growth | 1.87% | 178.88% | -16.91% | -58.92% | 162.55% | -31.79% | Upgrade
|
Enterprise Value | 76,123 | 96,197 | 55,452 | 54,820 | 95,516 | 45,851 | Upgrade
|
Last Close Price | 608.40 | 308.57 | 112.22 | 135.83 | 329.99 | 125.25 | Upgrade
|
PE Ratio | 16.34 | - | - | - | 28.22 | 79.29 | Upgrade
|
Forward PE | 11.98 | 26.97 | 22.79 | - | 22.19 | 9.30 | Upgrade
|
PS Ratio | 1.22 | 1.78 | 0.70 | 1.01 | 2.28 | 1.05 | Upgrade
|
PB Ratio | 2.46 | 3.48 | 1.19 | 1.31 | 2.69 | 1.11 | Upgrade
|
P/TBV Ratio | 5.33 | 6.75 | 2.28 | 2.49 | 4.52 | 1.86 | Upgrade
|
P/FCF Ratio | - | 12.37 | - | - | 41.18 | 52.67 | Upgrade
|
P/OCF Ratio | - | 10.29 | 58.22 | - | 15.73 | 14.09 | Upgrade
|
PEG Ratio | 4.38 | 4.38 | 4.38 | - | 0.10 | 0.10 | Upgrade
|
EV/Sales Ratio | 1.66 | 2.37 | 1.50 | 1.79 | 2.88 | 1.67 | Upgrade
|
EV/EBITDA Ratio | 9.72 | 13.92 | 16.29 | - | 16.07 | 8.68 | Upgrade
|
EV/EBIT Ratio | 12.99 | 18.69 | 38.52 | - | 22.31 | 12.27 | Upgrade
|
EV/FCF Ratio | - | 16.50 | - | - | 51.92 | 83.69 | Upgrade
|
Debt / Equity Ratio | 1.04 | 1.21 | 1.39 | 1.27 | 0.83 | 0.86 | Upgrade
|
Debt / EBITDA Ratio | 2.45 | 3.46 | 8.10 | - | 3.81 | 4.08 | Upgrade
|
Debt / FCF Ratio | - | 4.32 | - | - | 12.77 | 40.79 | Upgrade
|
Asset Turnover | - | 0.65 | 0.54 | 0.44 | 0.50 | 0.39 | Upgrade
|
Inventory Turnover | - | 1.59 | 1.52 | 1.36 | 1.43 | 1.45 | Upgrade
|
Quick Ratio | - | 0.55 | 0.59 | 0.58 | 0.52 | 0.52 | Upgrade
|
Current Ratio | - | 1.03 | 1.08 | 0.99 | 1.03 | 0.93 | Upgrade
|
Return on Equity (ROE) | - | -7.00% | -10.14% | -18.25% | 9.01% | 1.61% | Upgrade
|
Return on Assets (ROA) | - | 5.16% | 1.32% | -2.12% | 4.07% | 3.31% | Upgrade
|
Return on Capital (ROIC) | 9.99% | 6.57% | 1.70% | -2.81% | 5.36% | 4.29% | Upgrade
|
Return on Capital Employed (ROCE) | - | 17.39% | 3.95% | - | 10.01% | 10.36% | Upgrade
|
Earnings Yield | 62.94% | -0.98% | -7.84% | -14.79% | 3.54% | 1.26% | Upgrade
|
FCF Yield | 8.08% | -1.95% | -12.89% | 2.43% | 1.90% | Upgrade
| |
Dividend Yield | 0.40% | 0.81% | 1.34% | - | 0.76% | 1.60% | Upgrade
|
Payout Ratio | 0.00% | - | - | - | 6.67% | 84.58% | Upgrade
|
Buyback Yield / Dilution | -1.52% | -1.02% | -0.37% | -0.04% | -0.14% | -0.01% | Upgrade
|
Total Shareholder Return | -1.12% | -0.21% | 0.97% | -0.04% | 0.62% | 1.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.